Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Richard Rupp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation E in Healthy Adults
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
10/6/25 → 10/5/27
Project: Research project
-
A Phase 2, Randomized, Double-Blind, Active-Controlled, Dose-Finding Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants Given 4 Doses at 2, 4, 6, and 12-15 Months of Age Concomitantly with Routine Pediatr
Rupp, R. (PI)
3/11/25 → 3/10/30
Project: Research project
-
Teen Health Award 2025-2027
Rupp, R. (PI)
Sealy and Smith Foundation ( Award # )
1/1/25 → 12/31/27
Project: Research project
-
The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team, Mar 19 2026, In: Vaccine. 76, 128348.Research output: Contribution to journal › Article › peer-review
Open Access -
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
21-0012 Study Group, Feb 25 2026, In: Science Translational Medicine. 18, 838, eaeb9837.Research output: Contribution to journal › Article › peer-review
Open Access -
Vaccinology in the twenty-first century revisited
Barrett, A., Rupp, R. E., Titball, R. W. & von Messling, V., Dec 2026, In: npj Vaccines. 11, 1, 166.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
El Sahly, H. M., Anderson, E. J., Jackson, L. A., Neuzil, K. M., Atmar, R. L., Bernstein, D. I., Chen, W. H., Creech, C. B., Frey, S. E., Goepfert, P., Meier, J., Phadke, V., Rouphael, N., Rupp, R., Stapleton, J. T., Spearman, P., Walter, E. B., Winokur, P. L., Yildirim, I. & Williams, T. L. & 10 others, , Feb 15 2025, In: Vaccine. 47, 126689.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Mucosal and Systemic Antibody Responses after Boosting with a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
Division of Microbiology and Infectious Diseases (DMID) 21-0012 Study Group, Oct 15 2025, In: Journal of Infectious Diseases. 232, 4, p. 971-981 11 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Scopus citations